ARUP Laboratories Now Offers COVID-19 Saliva Testing – Available with Preapproval to ARUP Clients Nationwide

Monday, September 21, 2020

September 11, 2020

ARUP Laboratories reports their molecular diagnostic test is available with preapproval to ARUP clients nationwide. COVID-19 testing on saliva specimens offers significant benefits to both individuals and healthcare providers. Spitting into a funnel attached to the top of a collection tube is less invasive than a deep nasal swab performed by a healthcare provider. Providers benefit because they face less risk of exposure by infected individuals who cough or sneeze after enduring a nasopharyngeal swab.

ARUP Laboratories will perform the test only on saliva specimens collected using an ARUP collection kit with a healthcare provider present. ARUP validated the test using its kit on high-throughput instruments, and cannot perform it on other saliva specimens without jeopardizing quick turnaround times, said Adam Barker, Ph.D., director of ARUP’s new COVID-19 Rapid Response Lab.

“Offering accurate, high-quality COVID-19 testing and delivering results quickly to as many patients as possible is part of our commitment to excellent patient care,” Barker said.

ARUP moved quickly to offer COVID-19 saliva testing after researchers at ARUP and University of Utah Health found self-collected saliva and nasopharyngeal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19. Their study, published in the Journal of Clinical Microbiology, is one of the largest specimen-type comparisons to date.

U of U Health began offering ARUP’s COVID-19 saliva test on Sept. 1, and is using this specimen source to test for COVID-19 infection in most clinical settings. ARUP is a nonprofit enterprise of the U of U and its Department of Pathology. In addition to performing all testing for U of U Health, ARUP has thousands of hospital and health-system clients nationwide.

“We’re pleased to be one of the first labs to offer a COVID-19 saliva test that makes high-quality testing easier for patients and for providers,” said ARUP CEO Sherrie L. Perkins, MD, PhD. “ARUP remains committed to research, development and performance of tests that improve diagnosis of COVID-19 and all other diseases.”

In addition to COVID-19 molecular diagnostic testing, ARUP offers two IgG antibody tests to detect previous exposure to SARS-CoV-2. It also offers numerous tests that help guide treatment of the virus.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here